Hidradenitis suppurativa (acne inversa): Treatment with deroofing and resorcine;Hidradenitis suppurativa (acne inversa): Behandeling met deroofing en resorcine

Nederlands Tijdschrift voor Dermatologie en Venereologie

Volumn 14, Issue 7, 2004, Pages 274-278

  Boer, Jurr ^a   Bos, Wim H ^b   Van Der Meer, Jan B ^b  

^a DEVENTER HOSPITAL   (Netherlands)

^b NONE

Author keywords

Acne inversa; Deroofing; Hidradenitis suppurativa; Resorcine; Therapie

Indexed keywords

ANTIBIOTIC AGENT; ETRETIN; ISOTRETINOIN; KERATIN; KERATOLYTIC AGENT; RESORCINOL; SYMBIAL;

ABSCESS; ACNE; ACNE INVERSA; APOCRINE GLAND; COLLAPSE; DERMATITIS; HUMAN; HYPOTHYROIDISM; PAIN; PATHOGENESIS; PUS; RECURRENCE RISK; REVIEW; SIDE EFFECT; SUPPURATIVE HIDRADENITIS; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 4644236565     PISSN: 09258604     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Yu CC, Cook MG. Hidradenitis suppurativa: a disease of follicular epithelium rather than apocrine glands. Br J Dermatol 1990;122:763-9.
2. Attanous R, Appleton MAC, Douglas-Jones AG. The pathogenesis of hidradenitis suppurativa: a closer look at apocrine and apoeccrine glands. Br J Dermatol 1995;133:254-8.
3. Plewig G, Steger M. Acne inversa (alias acne triad, acne tetrad or hidradenitis suppurativa). In: Marks R, Plewig G, red. Acne and related disorders. London: Martin Dunitz, 1991:345-57.
4. Boer J, Weltevreden EF. Hidradenitis suppurativa or acne inversa: a clinicopathological study of early laesions. Br J Dermatol 1996;135:721-5.
5. de Groot AC, Sigurdsson V, van der Stek J. Acne inversa: Huidige inzichten. Ned Tijdschr Derm Venereol 2004;14: 225-31.
6. Jansen T, Altmeijer P, Plewig G. Acne inversa (alias hidradenitis suppurativa). J Eur Acad Derm Venereol 2001;15:532-40.
7. Slade DEM, Powell BW, Mortimer PS. Hidradenitis suppurativa: pathogenesis and management. Plast Reconstr Surg 2003;56:451-61.
8. Jemec GBE. What's new in hidradenitis suppurativa? J Eur Acad Derm Venereol 2000;14:340-1.
9. Mortimer P. Management of hidradenitis suppurativa. Clin Exp Dermatol 2002;27:332.
10. Hurley HJ. Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa, and familial benign pemphigus: Surgical approach. In: Roenigk RK en Roenigk HHJ, red. Dermatologic surgery: Principles and practice. New York: Marcel Dekker, 1989;717-43.
11. Jemec G, Heidenheim M, Nielsen NH. Hidradenitis suppurativa- characteristics and consequences. Clin Exp Dermatol 1996;21:419-23.
12. Polano MK. Phenol derivates. In: Topical therapeutics. Chuchill Livingstone: Edinburgh-London, 1984:70-1.
13. Degreef H, Hulsebosch HJ, Mariën KJC, Schroeff JG van der. Behandelingsprincipes. In: Vloten WA van, Degreef HJ, Stolz E, Vermeer BJ, Willemze R, red. Dermatologie en Venereologie, 3e ed. Maarssen: Elsevier Gezondheidszorg, 2000:52.
14. Groot de AC. Dermatological drugs, topical agents and cosmetics. In: Dukes MNG en Aronson JK, red. Meyler's side effects of drugs, 14e ed. Amsterdam: Elsevier, 2000:473.
15. Mills OH, Kligman AM. Drugs that are ineffective in the treatment of acne vulgaris. Br J Dermatol 1983;108:371-4.
16. Wüthrich B, Zabrodsky S, Storck H. Perkutane Vergiftungen durch Resorcin, Salicylsäure und weisse Präcipitatsalbe. Pharmaceutica Acta Helvetiae 1970;45:453-60.
17. Boer J, Dijkstra AT, Baar TJM, van der Meer JB. Hidradenitis suppurativa (acne inversa): lokale behandeling met resorcine. Ned Tijdschr Derm Venereol 2001;11:348-9.
18. Boer J. Hidradenitis suppurativa (acne inversa). In: Bergman W, Vliet-Vlieland CW, Went PBM, red. Dermatologie. Boerhaave cursus, 2003:43-8.
19. Häckh G, Schwarzmüller E. Codex dermatologischer Wirkstoffe. In: Niedner R en Ziegenmeyer J, red. Dermatika. Stuttgart: Wissenschaftliche Verlagsgesellschaft, 1992:447-8.
20. Bontemps H, Mallaret M, Besson G, Bochaton H, Carpentier F. Confusion after topical use of resorcinol. Arch Dermatol 1995;131:112.
21. Cunliffe WJ. Looking back to the future: Acne. Dermatology 2002;204:167-72.
22. Cassano N, Alessandrini G, Mastrolonardo M, Vena GA. Peeling agents: toxicological and allergological aspects. J Eur Acad Dermatol Venereol 1999;13:14-23.
23. Cunningham AA. Resorcine poisoning. Arch Dis Child 1956; 31:173-6.
24. Smeenk G. Bijwerkingen en beperkingen van de lokale behandeling van acne. In: Vloten WA van, red. Acne vulgaris, wat doen we eraan? Bussum: Medicom Europe, 1989:84-90.
25. Mullins JF. Surgical treatment of chronic hidradenitis suppurativa. In: Epstein E, red. Skin surgery, 2e ed. Philadelphia: Lea and Febiger, 1962:326-30.
26. Barron J.The surgical treatment of perianal hidradenitis suppurativa. Dis Col and Rect 1970;13:441-3.
27. Newell GB, Voelter WW, Mullins JF. Treatment of hidradenitis suppurativa. JAMA 1973;223:556.
28. Brown SCW, Kazzari N, Lord PH. Surgical treatment of perianal hidradenitis suppurativa with special reference to recognition of the perianal form. Br J Surg 1986;73:978-80.
29. Plas M van der, Bos WH. Chirurgische behandeling (epitheliale adnexcysten) door de dermatoloog. Ned Tijdschr Derm Venereol 1994;4:101-3.
30. Wal VB van der, Bos WH. Chirurgische behandeling van acne ectopica met "deroofing"(methode Bos): 1994-1999. Ned Tijdschr Derm Venereol 2000;10:22-3.
31. Finlay EM, Ratz JL. Treatment of hidradenitis suppurativa with carbon dioxide laser excision and second-intention healing. J Am Acad Dermatol 1996;34:465-9.
32. Lapins J, Marcusson JA, Emtestam L. Surgical treatment of chronic hictradenitis suppurativa: CO2 laser stripping-secondary intention technique. Br J Dermatol 1994;131:551-6.
33. Boer J, van Gemert MJ. Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa. J Am Acad Dermatol 1999;40:73-6.
34. Groot de AC, Conemans JMH, Hoek van der EW, Oyen van LM, Sigurdsson V. Infliximab (I). Therapeutische rol in de gastro-enterologie en de dermatologie. Ned Tijdschr Derm Venereol 2003;13:270-5.